Cumulative probability of high-grade dysplasia, pancreatic ductal adenocarcinoma 26 percent at 10 years in high-risk individuals with MPD dilation ...

Topline data were announced from a phase 3 trial evaluating giredestrant for the adjuvant treatment of estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, ...

Funding accounted for 34.5 percent of total financial assistance requested in campaigns initiated between Jan. 1, 2021, and Feb. 28, 2023.

In this cross-sectional analysis, researchers aimed to characterize the NIH trials affected by grant terminations under the Trump administration.

The phase 2 ChonDRAgon study compared ozekibart to placebo in patients with metastatic or unresectable conventional chondrosarcoma who been diagnosed with radiographic progression.

In this study, researchers examined associations between multiple primary cancer incidence and county-level smoking prevalence.

This retrospective cohort study used data from the Veterans Health Administration to assess the association between chronic untreated HCV and incident PDAC and whether different HCV genotypes affect ...

Researchers investigated the potential association between early-onset conventional adenomas, which are precursors to CRC, and serrated lesions, and higher intake of ultraprocessed foods.

A collaborative quality improvement initiative involving ACS-accredited radiotherapy programs sought to improve no show rates in patients with cancer.

Future research should focus on implementation studies and effectiveness in clinical settings and explore the applicability of TG-iConquerFear across different cancer types,” study researchers noted.

Study researchers found no link between more liver fat and poor outcomes in patients with stage I-III rectal cancer.

Barbara Burtness, MD highlights key news in head and neck cancer from ESMO 2025, including CAMORAL, ASPEN-03 & -04, OrigAMI-4 & -05 results.